Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acupuncture Therapy | 19 | 2024 | 486 | 5.110 |
Why?
|
Hot Flashes | 2 | 2024 | 330 | 0.920 |
Why?
|
Peripheral Nervous System Diseases | 2 | 2020 | 716 | 0.890 |
Why?
|
Deglutition Disorders | 3 | 2016 | 637 | 0.840 |
Why?
|
Drugs, Chinese Herbal | 4 | 2013 | 148 | 0.840 |
Why?
|
Fluorouracil | 3 | 2013 | 1656 | 0.810 |
Why?
|
Acupuncture Analgesia | 2 | 2018 | 63 | 0.690 |
Why?
|
Antineoplastic Agents | 8 | 2020 | 13708 | 0.620 |
Why?
|
Plant Extracts | 2 | 2011 | 499 | 0.580 |
Why?
|
Neoplasms | 13 | 2023 | 22386 | 0.470 |
Why?
|
Head and Neck Neoplasms | 3 | 2016 | 2915 | 0.470 |
Why?
|
Breast Neoplasms | 6 | 2024 | 21156 | 0.440 |
Why?
|
Salvia miltiorrhiza | 1 | 2013 | 3 | 0.430 |
Why?
|
Panax | 1 | 2013 | 28 | 0.420 |
Why?
|
Taxus | 1 | 2011 | 2 | 0.400 |
Why?
|
Pain, Intractable | 1 | 2013 | 132 | 0.390 |
Why?
|
Quality of Life | 7 | 2024 | 13497 | 0.380 |
Why?
|
Camellia sinensis | 1 | 2011 | 8 | 0.380 |
Why?
|
Nausea | 2 | 2022 | 682 | 0.380 |
Why?
|
Vomiting | 2 | 2022 | 655 | 0.370 |
Why?
|
Medical Oncology | 4 | 2018 | 2347 | 0.350 |
Why?
|
Integrative Medicine | 1 | 2009 | 87 | 0.300 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2011 | 647 | 0.280 |
Why?
|
Academies and Institutes | 1 | 2009 | 326 | 0.280 |
Why?
|
Acupuncture Points | 2 | 2024 | 111 | 0.270 |
Why?
|
Leukopenia | 1 | 2007 | 214 | 0.260 |
Why?
|
Acupuncture | 1 | 2005 | 90 | 0.240 |
Why?
|
Republic of Korea | 2 | 2024 | 587 | 0.240 |
Why?
|
Drug Synergism | 4 | 2014 | 1765 | 0.240 |
Why?
|
Neutropenia | 1 | 2009 | 892 | 0.220 |
Why?
|
Acupressure | 1 | 2023 | 16 | 0.220 |
Why?
|
Pilot Projects | 6 | 2023 | 8730 | 0.220 |
Why?
|
Radiotherapy | 2 | 2009 | 1510 | 0.200 |
Why?
|
Catechin | 2 | 2014 | 70 | 0.200 |
Why?
|
Acupuncture, Ear | 1 | 2022 | 13 | 0.200 |
Why?
|
Aristolochic Acids | 1 | 2000 | 13 | 0.180 |
Why?
|
China | 2 | 2024 | 2398 | 0.180 |
Why?
|
Phenanthrenes | 1 | 2000 | 66 | 0.180 |
Why?
|
Complementary Therapies | 2 | 2017 | 487 | 0.170 |
Why?
|
Colonic Diseases, Functional | 1 | 1999 | 39 | 0.170 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2012 | 4083 | 0.160 |
Why?
|
Combined Modality Therapy | 1 | 2010 | 8559 | 0.150 |
Why?
|
Urologic Neoplasms | 1 | 2000 | 319 | 0.140 |
Why?
|
Analgesics, Opioid | 1 | 2013 | 3837 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 3 | 2013 | 8201 | 0.130 |
Why?
|
Gastrointestinal Agents | 1 | 2001 | 510 | 0.130 |
Why?
|
Receptors, Estrogen | 1 | 2024 | 2243 | 0.130 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2024 | 1536 | 0.130 |
Why?
|
Infertility | 1 | 2022 | 654 | 0.120 |
Why?
|
Humans | 32 | 2024 | 768451 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2024 | 65409 | 0.120 |
Why?
|
Food-Drug Interactions | 1 | 2014 | 24 | 0.110 |
Why?
|
Pain | 2 | 2008 | 5096 | 0.110 |
Why?
|
Ovarian Neoplasms | 1 | 2009 | 4906 | 0.100 |
Why?
|
Tea | 1 | 2014 | 290 | 0.100 |
Why?
|
Cell Line, Tumor | 4 | 2013 | 17149 | 0.100 |
Why?
|
Salvia | 1 | 2011 | 13 | 0.100 |
Why?
|
Rats | 3 | 2013 | 23839 | 0.090 |
Why?
|
Female | 15 | 2024 | 396943 | 0.090 |
Why?
|
Lactates | 1 | 2011 | 401 | 0.090 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2013 | 1339 | 0.090 |
Why?
|
Patient Dropouts | 1 | 2012 | 411 | 0.080 |
Why?
|
Massage | 1 | 2009 | 86 | 0.080 |
Why?
|
Intubation, Gastrointestinal | 1 | 2010 | 166 | 0.080 |
Why?
|
United States | 5 | 2024 | 73121 | 0.080 |
Why?
|
Deglutition | 1 | 2010 | 208 | 0.080 |
Why?
|
Feasibility Studies | 3 | 2022 | 5308 | 0.080 |
Why?
|
Diet Therapy | 1 | 2009 | 151 | 0.080 |
Why?
|
Middle Aged | 9 | 2024 | 223418 | 0.080 |
Why?
|
Gastrostomy | 1 | 2010 | 325 | 0.070 |
Why?
|
Adult | 9 | 2024 | 223542 | 0.070 |
Why?
|
Aged | 7 | 2024 | 171520 | 0.070 |
Why?
|
Area Under Curve | 1 | 2011 | 1640 | 0.070 |
Why?
|
Guidelines as Topic | 1 | 2013 | 1395 | 0.070 |
Why?
|
Drug Therapy | 1 | 2009 | 504 | 0.070 |
Why?
|
Clinical Protocols | 1 | 2012 | 1444 | 0.070 |
Why?
|
Societies, Medical | 1 | 2018 | 3955 | 0.060 |
Why?
|
Meta-Analysis as Topic | 1 | 2010 | 1364 | 0.060 |
Why?
|
Yoga | 1 | 2009 | 281 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3104 | 0.060 |
Why?
|
Cancer Care Facilities | 1 | 2008 | 424 | 0.060 |
Why?
|
Leukocyte Count | 1 | 2009 | 1604 | 0.060 |
Why?
|
Biomedical Research | 2 | 2017 | 3463 | 0.060 |
Why?
|
Neuroprotective Agents | 1 | 2011 | 960 | 0.060 |
Why?
|
Cell Survival | 2 | 2011 | 5801 | 0.060 |
Why?
|
Enteral Nutrition | 1 | 2010 | 804 | 0.060 |
Why?
|
Palliative Care | 2 | 2010 | 3644 | 0.060 |
Why?
|
Anxiety | 2 | 2009 | 4655 | 0.060 |
Why?
|
Drug Discovery | 1 | 2011 | 1062 | 0.050 |
Why?
|
Antioxidants | 1 | 2011 | 1678 | 0.050 |
Why?
|
Cell Cycle | 1 | 2011 | 2942 | 0.050 |
Why?
|
Male | 9 | 2023 | 364781 | 0.050 |
Why?
|
BRCA1 Protein | 1 | 2009 | 1158 | 0.050 |
Why?
|
Skin Temperature | 1 | 2022 | 96 | 0.050 |
Why?
|
Animals | 6 | 2014 | 169418 | 0.050 |
Why?
|
Radionuclide Imaging | 1 | 2005 | 1998 | 0.050 |
Why?
|
Fatigue | 1 | 2008 | 1556 | 0.050 |
Why?
|
Mastectomy | 1 | 2009 | 1852 | 0.050 |
Why?
|
Fenfluramine | 1 | 2000 | 58 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7451 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2008 | 10358 | 0.040 |
Why?
|
Acetazolamide | 1 | 2000 | 96 | 0.040 |
Why?
|
Patient Selection | 1 | 2012 | 4266 | 0.040 |
Why?
|
Gastrointestinal Diseases | 1 | 2008 | 1207 | 0.040 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2008 | 1097 | 0.040 |
Why?
|
Leukocytes | 1 | 2007 | 2030 | 0.040 |
Why?
|
Urothelium | 1 | 2000 | 275 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2012 | 12450 | 0.040 |
Why?
|
Infant | 1 | 2019 | 36497 | 0.040 |
Why?
|
Anti-Obesity Agents | 1 | 2000 | 230 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2013 | 10494 | 0.030 |
Why?
|
Child, Preschool | 1 | 2019 | 42623 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 300 | 0.030 |
Why?
|
Research Design | 1 | 2012 | 6217 | 0.030 |
Why?
|
Drug Interactions | 1 | 2000 | 1421 | 0.030 |
Why?
|
Apoptosis | 1 | 2011 | 9526 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2009 | 4538 | 0.030 |
Why?
|
Brain Mapping | 1 | 2008 | 6740 | 0.030 |
Why?
|
Aged, 80 and over | 2 | 2023 | 59680 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8051 | 0.030 |
Why?
|
Child | 1 | 2019 | 80863 | 0.020 |
Why?
|
Alzheimer Disease | 1 | 2011 | 8721 | 0.020 |
Why?
|
Phytotherapy | 1 | 2011 | 298 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2011 | 564 | 0.020 |
Why?
|
Depression | 1 | 2008 | 8235 | 0.020 |
Why?
|
Cytokines | 1 | 2023 | 7449 | 0.020 |
Why?
|
Neurotoxicity Syndromes | 1 | 2011 | 303 | 0.020 |
Why?
|
Disease Management | 1 | 2017 | 2533 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3708 | 0.020 |
Why?
|
Young Adult | 1 | 2012 | 60045 | 0.020 |
Why?
|
Mice | 1 | 2011 | 82045 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2022 | 22293 | 0.010 |
Why?
|
Adolescent | 1 | 2012 | 89168 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2011 | 2834 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2011 | 10784 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2010 | 2780 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2011 | 5152 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 2011 | 3891 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2023 | 81834 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2010 | 15965 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39430 | 0.000 |
Why?
|
Time Factors | 1 | 2010 | 40271 | 0.000 |
Why?
|
Prospective Studies | 1 | 2010 | 54914 | 0.000 |
Why?
|
Concepts
(143)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_